Literature DB >> 18006902

Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.

M Kyla Shea1, Sarah L Booth, Joseph M Massaro, Paul F Jacques, Ralph B D'Agostino, Bess Dawson-Hughes, José M Ordovas, Christopher J O'Donnell, Sekar Kathiresan, John F Keaney, Ramachandran S Vasan, Emelia J Benjamin.   

Abstract

In vitro data suggest protective roles for vitamins K and D in inflammation. To examine associations between vitamins K and D and inflammation in vivo, the authors used multiple linear regression analyses, adjusted for age, sex, body mass index, triglyceride concentrations, use of aspirin, use of lipid-lowering medication, season, menopausal status, and hormone replacement therapy. Participants were from the Framingham Offspring Study (1997-2001; n = 1,381; mean age = 59 years; 52% women). Vitamin K status, measured by plasma phylloquinone concentration and phylloquinone intake, was inversely associated with circulating inflammatory markers as a group and with several individual inflammatory biomarkers (p < 0.01). Percentage of undercarboxylated osteocalcin, a functional measure of vitamin K status, was not associated with overall inflammation but was associated with C-reactive protein (p < 0.01). Although plasma 25-hydroxyvitamin D was inversely associated with urinary isoprostane concentration, an indicator of oxidative stress (p < 0.01), overall associations between vitamin D status and inflammation were inconsistent. The observation that high vitamin K status was associated with lower concentrations of inflammatory markers suggests that a possible protective role for vitamin K in inflammation merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006902      PMCID: PMC3151653          DOI: 10.1093/aje/kwm306

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  48 in total

1.  Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.

Authors:  Anders Vik; Ellisiv B Mathiesen; Ann-Trude W Notø; Baldur Sveinbjørnsson; Jan Brox; John-Bjarne Hansen
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

2.  Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample.

Authors:  P F Jacques; D T Felson; K L Tucker; B Mahnken; P W Wilson; I H Rosenberg; D Rush
Journal:  Am J Clin Nutr       Date:  1997-10       Impact factor: 7.045

3.  Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection.

Authors:  K W Davidson; J A Sadowski
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds.

Authors:  K Reddi; B Henderson; S Meghji; M Wilson; S Poole; C Hopper; M Harris; S J Hodges
Journal:  Cytokine       Date:  1995-04       Impact factor: 3.861

6.  Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.

Authors:  M J Barger-Lux; R P Heaney; S Dowell; T C Chen; M F Holick
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

7.  Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium.

Authors:  V Panichi; S De Pietro; B Andreini; A M Bianchi; M Migliori; D Taccola; L Giovannini; C Tetta; R Palla
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

8.  Phylloquinone in plasma from elderly and young adults: factors influencing its concentration.

Authors:  J A Sadowski; S J Hood; G E Dallal; P J Garry
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

9.  Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.

Authors:  C M Gundberg; S D Nieman; S Abrams; H Rosen
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity.

Authors:  Y Koshihara; K Hoshi; M Shiraki
Journal:  Biochem Pharmacol       Date:  1993-10-19       Impact factor: 5.858

View more
  110 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

2.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

Review 3.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

4.  Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis.

Authors:  Eri Shiraishi; Hideki Iijima; Shinichiro Shinzaki; Sachiko Nakajima; Takahiro Inoue; Satoshi Hiyama; Shoichiro Kawai; Manabu Araki; Toshio Yamaguchi; Yoshito Hayashi; Hironobu Fujii; Tsutomu Nishida; Masahiko Tsujii; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2015-08-28       Impact factor: 7.527

5.  Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population.

Authors:  Seckin Satilmis; Omer Celik; Ismail Biyik; Derya Ozturk; Kubra Celik; Fatih Akın; Burak Ayca; Burce Yalcin; Sinan Dagdelen
Journal:  Bosn J Basic Med Sci       Date:  2015-02-08       Impact factor: 3.363

6.  Calcitriol plays a protective role in diabetic nephropathy through anti-inflammatory effects.

Authors:  Li Mao; Feng Ji; Yuanyuan Liu; Wei Zhang; Xianghua Ma
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients.

Authors:  Wei Ren Chen; Zhi Ying Liu; Yang Shi; Da Wei Yin; Hao Wang; Yuan Sha; Yun Dai Chen
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-11-08       Impact factor: 1.468

8.  Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

9.  Association between vitamin D levels and blood pressure in a group of Puerto Ricans.

Authors:  Yajaira Caro; Verónica Negrón; Cristina Palacios
Journal:  P R Health Sci J       Date:  2012-09       Impact factor: 0.705

10.  Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women.

Authors:  Jin Xia; Wanzhu Tu; JoAnn E Manson; Hongmei Nan; Aladdin H Shadyab; Jennifer W Bea; Ting-Yuan D Cheng; Lifang Hou; Yiqing Song
Journal:  Am J Clin Nutr       Date:  2020-08-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.